Back to search

Article

Polyvalent mRNA vaccination elicited potent immune response to monkeypox surface antigens

2022-11-29

Abstract excerpt

The soaring global monkeypox cases lead to a surge in demand for monkeypox vaccine, which far exceeds the supply. mRNA vaccine has achieved great success in prevention of coronavirus disease and holds promise against diverse pathogens. In this study, we generate a polyvalent lipid nanoparticle (LNP) mRNA vaccine candidate for monkeypox virus (MPXV) and evaluate its immunogenicity in animal models. This polyvalent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f1249e8-cced-5bdd-9e94-a0a55de7e774
DOI
10.1101/2022.11.29.518427
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Polyvalent mRNA vaccination elicited potent immune response to monkeypox surface antigensDOI 10.1101/2022.11.29.518427
Select a neighboring publication to make it the new centre.